NRF2 is directly involved in promoting cisplatin resistance by maintaining a high expression of ROS scavenging proteins, which prevents the accumulation of ROS in steady state conditions, preventing cancer cells from dying [63]. The gene discussed is NFE2L2; the disease is cancer.